Pulmonary toxicity associated with pomalidomide-Reference-Cited by-同舟云学术

Pulmonary toxicity associated with pomalidomide

Published:2018-11-01 Issue:11 Volume:22 Page:1383-1386
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Gajic S.¹,Callahan E. C.²,Brown J. K.³,Elicker B.⁴,Ley B.⁵,Blanc P. D.⁶

Affiliation:

1. Department of Medicine

2. Department of Anesthesia, University of California, San Francisco (UCSF), San Francisco, California

3. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Veterans Affairs Medical Center, and Department of Medicine, UCSF, San Francisco, California

4. Departments of Radiology and Biomedical Imaging

5. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine

6. Division of Occupational and Environmental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pomalidomide-induced lung injury: A case report;Medicine;2023-01-13

2. Severe lung injury induced by CD38 monoclonal antibody Daratumumab and bortezomib‐containing regimen in a patient with preexisting interstitial lung disease: a case report and literature review;Journal of Clinical Pharmacy and Therapeutics;2022-12

3. A Review of Interstitial Pneumonitis Caused by Elotuzumab Through Case Discussions and Academic Writings;Cureus;2020-10-25

4. The Adverse Drug Reactions Registered During the Postmarketing Period;Safety and Risk of Pharmacotherapy;2019-03-25

5. Pomalidomide;Reactions Weekly;2018-11